American Century Companies
PLRX icon

American Century Companies’s Pliant Therapeutics PLRX Stock Holding History

American Century Companies’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-110,093
Closed -$149K – 2918
2025
Q1 		$149K Buy
110,093
+9,244
+9% +$56.1K ﹤0.01% 2795
2024
Q4 		$1.33M Buy
100,849
+9,944
+11% +$136K ﹤0.01% 2161
2024
Q3 		$1.02M Buy
90,905
+16,792
+23% +$210K ﹤0.01% 2226
2024
Q2 		$797K Buy
74,113
+11,351
+18% +$146K ﹤0.01% 2262
2024
Q1 		$935K Buy
62,762
+31,867
+103% +$526K ﹤0.01% 2178
2023
Q4 		$560K Buy
+30,895
New +$470K ﹤0.01% 2327

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

American Century Companies's PLRX Position: Q2 2025 in Review

American Century Companies sold out of Pliant Therapeutics (PLRX) in Q2 2025, closing a stake of 110,093 shares — an estimated $149K sold.

American Century Companies first reported a position in PLRX in Q4 2023 and held it in 6 quarters. The position peaked at $1.33M in Q4 2024. 114 funds tracked by Wall St. Rank hold PLRX as of Q2 2025.

  • American Century Companies reported no remaining Pliant Therapeutics position as of Q2 2025 after selling out during the quarter.
  • American Century Companies sold 110,093 Pliant Therapeutics shares in Q2 2025, an estimated $149K.
  • American Century Companies first reported a position in Pliant Therapeutics in Q4 2023 and held it in 6 quarters.
  • American Century Companies's Pliant Therapeutics position peaked at $1.33M in Q4 2024.
  • 114 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2025.

Based on American Century Companies's 13F filing for Q2 2025, filed 12 Aug 2025.